Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
we have to because the stock is NOT liquid enough to get out..lol
i was hoping for some news today because of the video they posted back on Feb 20th on their FB page about some big coming. I hope happens soon and helps the stock move up !!
im not sure if its patience or stock w/ the stock till something happens..
it would be great to FINALLY hear something from the company... not sure how many more marketing videos w/ little views will help them out as far as people downloading their app(s)....
more teasing from PDPR/ livod https://www.facebook.com/outdoorlife4fun/videos/683397631869107/
It sure would be nice for news to be streamed from Livod tomorrow...
it would be nice for a open letter to the shareholders or something regarding this stock after 18 months of nothing..
just read the 10k out last week, this company has some interesting PATENTS going on
PATENT TITLE USE OF PATENT APPLICATION #
A Business Method for “Collection, Cryogenic Storage and Distribution of a Biological Sample Material” Company Core Tissue Collection Processing and Storage Methodology U.S. Serial No. 13/702,304 filed June 6, 2011, and claiming a priority date of June 7, 2010 from provisional application 61/352,217
Systems and Methods for “The Digestion of Adipose Tissue Samples Obtained From a Client for Cryopreservation” Adipose Tissue Digestion Laboratory Processing Methods U.S. Serial No. 13/646,647 filed October 5, 2012, and claiming a priority date of October 6, 2011 from provisional application 61/544,103
Compositions and Methods for “Collecting, Washing, Cyroprocessing, Recovering and Return of Lipoaspirate to Physicians for Autologous Adipose Transfer Procedures” Company Adipose Tissue Storage Platform for Cosmetic Procedures PCT/US13/44621 Filed June 6, 2013 and claiming a priority date of June 7, 2012
Stem Cell-Based Therapeutic Devices and Methods Combining ADRCs with Biomaterials for healing and tissue growth U. S. Serial No. 14/196,616 filed March 4, 2014 and claiming a priority date from provisional application 61/773,112 filed March 5, 2013
Autologous Serum for Transport of Isolated Stromal Vascular Fraction or Adipose Derived Stem Cells Utilization of Autologous Blood Components for the Transport of Adipose Derived Cells to a Patient
U.S. Serial No. 14,250,338 and claiming a priority date from provisional application 61/810,970
filed April 11, 2013
Human Serum for Cell Culture Medium for Clinical Growth of Human Adipose Stromal Cells International PCT filing of US Provisional Application Serial Number 62/098799 Filed December 31, 2014 PCT/US/68350 Filed December 31, 2015
Systems and Methods to isolate and Expand Stem Cells from Urine New Provisional Patent Application for a new source of human stem cells Provisional Patent Application No. 62/335,426
Additionally, the Company has in-licensed the following IP:
PATENT TITLE USE OF PATENT APPLICATION #
Cosmetic compositions including tropoelastin isomorphs Protein Genomics and American CryoStem (Autogenesis) collaboration USPTO #5,726,040
Cosmetic compositions Protein Genomics and American CryoStem (Autogenesis) collaboration USPTO #6,451,326
Recombinant hair treatment compositions Protein Genomics and American CryoStem (Autogenesis) collaboration USPTO #6,572,845
Wound healing compositions and methods using tropoelastin and lysyl oxidase Protein Genomics and American CryoStem (Autogenesis) collaboration USPTO: #6,808,707
Business methods, processes and systems for collection, cryogenic storage and distribution of cosmetic formulations from an obtained stem cell based biological Personal Cell Sciences and American CryoStem collaboration USPTO application #61/588,841
14
new link out from CRYO
NEW youtube video out today from CRYO
i agreed !! This company has dome NOTHING but post social media posts regarding LIVOD... No one is liking it on FB and VERY FEW on Instagram and twitter... STOP posting and START releasing news stories or sell the Shell to a REAL COMPANY They need to GO LIV w PR on LIVOD !!lol
63500 on the bid @ .25 !!
I agree, with the last news release it sounds like a ton of things are happening here... HOLD on for the ride !!
So true ...lol I've been here well over a year and NO news, No shareholder update and just a lot of NOTHING.. they do have a CRAP load of post on social media about going live on livod.. i'd like to see a press release go live on lIVOD !!
btw- with Zero information from the company investors have lost interest in this stock..
we ALL have for over a year and NOTHING...
KEEP an EYE on CRYO's volume is starting to pick up with 49,576 shares traded today
wow, sure are a ton of 1 share trades over the past 2 months..lol
Time and Sales for Marathon Group Corp (PDPR) Jan 05, 2017
Symbol:
PDPR
GO
Time Price Volume Market
01/03 0.0025 1 OTO
12/30 0.00273 1 OTO
12/28 0.0025 1 OTO
12/23 0.0025 1 OTO
12/22 0.0035 100000 OTO
12/22 0.0035 10000 OTO
12/22 0.0035 50000 OTO
12/22 0.0035 1 OTO
12/15 0.0025 1 OTO
12/08 0.01 2500 OTO
12/05 0.0028 80000 OTO
11/29 0.0028 1 OTO
11/21 0.0028 1 OTO
11/18 0.0029 100000 OTO
11/16 0.00313 30 OTO
11/14 0.0029 47800 OTO
11/14 0.0029 52200 OTO
11/14 0.0029 119800 OTO
11/14 0.0033 92000 OTO
11/14 0.0029 10000 OTO
11/14 0.0029 10000 OTO
11/04 0.0029 95000 OTO
11/01 0.0029 1 OTO
10/31 0.003153 1 OTO
10/28 0.00345 1 OTO
10/24 0.0029 90000 OTO
10/24 0.0029 10000 OTO
10/13 0.0029 1 OTO
10/11 0.003086 360000 OTO
10/11 0.0033 10000 OTO
I wonder where the timmage trader is on PDPR? probably (IMO) pumping up another stock..
looks like CRYO is on the move... Bid and Ask have closed the gap.
nothing is going to happen here ( i hope im WRONG) for a LONG time... check out stock CRYO... just released amazing news today ..
amazing news out on CRYO
American Cryostem 2016 Year End Update
EATONTOWN, NJ / ACCESSWIRE / January 4, 2017 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company's year ending September 30, 2016;
- The Company's Total Revenue increased 75% in Fiscal 2016 versus 2015
- Contributing to the Total Revenue increase for Fiscal 2016, International Revenue increased 19% in Fiscal 2016 versus Fiscal 2015
- Accounts Receivable increased 15% in Fiscal 2016 versus Fiscal 2015
- Tissue storage and processing increased 289% in Fiscal 2016 versus Fiscal 2015
- Research & Development decreased 60% in Fiscal 2016 compared to Fiscal 2015 which is attributed to; the completion of certain research projects
- Professional fees increased (principally legal and accounting) 130% in Fiscal 2016 compared to Fiscal 2015 due to an increase in legal expenses for the prosecution of our international patent portfolio, and optimization and scale up work associated with the licensing of our patented cell culture media, ACSelerate Max, to PeproTech in 2016
"American CryoStem's 2016 results reflect an increased interest by the medical and patient populations to seek out natural cosmetic solutions and products, and cellular therapies as alternative treatments for those that are not responding to traditional treatment solutions. We believe that we are well positioned to respond to these increased interests and look forward to continuing our year over year positive results," stated Anthony Dudzinski, COO.
John S. Arnone, CEO stated, "We are very optimistic about the state of the Regenerative Medicine Industry in the United States and globally as we enter 2017. We have seen a steady increase of new patients storing their stem cells for future use and physicians utilizing our products and service in 2016. We are in discussions for new global territories with licensees seeking to establish our adipose tissue (fat) based collect-process-store, stem cell platform in their country." This increased interest in cellular therapies is evidenced in eight thousand (8,000+) plus clinical trials currently registered with ClinicalTrials.gov focused on adipose tissue and its derivatives which include; adipose tissue (2,083), adult stem cells (5,709), adipose derived stem cells, mesenchymal stem cells and stromal vascular fraction (SVF). Arnone further stated, "In 2017 we look forward to expanding our US based physician network, patient stem cell storages and increasing our global laboratory footprint as regenerative and personalized medicine applications become main stream."
In 2017 management intends to continue its focus on increasing revenue, reducing costs and plans to begin a comprehensive investor and customer relations programs in Fiscal 2017.
About American CryoStem Corporation
American CryoStem Corporation (OTC PINK: CRYO); was founded in 2008, and has evolved to become a biotechnology pioneer, standardizing adipose tissue derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The Company operates a state-of-art, FDA-registered, clinical laboratory in New Jersey and licensed laboratories in Hong Kong, China and Tokyo, Japan, operating on our proprietary platform, dedicated to the collection, processing, bio-banking, culturing and differentiation of adipose tissue (fat) and adipose derived stem cells (ADSCs) for current or future use in regenerative medicine. CRYO maintains a strategic portfolio of intellectual property (IP) that surrounds our proprietary technology which supports a growing pipeline of stem cell applications and biologic products. We are leveraging our proprietary, IRB approved, FDA compliant platform and a developed product portfolio to create a domestic and global footprint of licensed laboratory affiliates, physicians networks and research organizations who purchase tissue collection, processing and storage consumables from our Company. Our laboratory stem cell bank/line products are characterized adult human Mesenchymal Stem Cell (MSC's) derived from adipose tissue that work in conjunction with our 13 patented (non-animal) medium lines. The Company's R&D efforts are focused on university and private collaborations to discover, develop and commercialize ADSC therapies by utilizing our standardized collection-processing-storage methodology and laboratory products combined with synergistic technologies to create jointly developed regenerative medicine applications and intellectual property.
For further detailed corporate or Regenerative Medicine information please visit:
www.americancryostem.com, request by email at info@americancryostem.com or phone 732-747-1007
SOURCE: American CryoStem Corporation
© Copyright © 2017 Accesswire. All rights reserved.
2017 begins and still NO updates or News from this company...very SAD !!
It sure would be NICE to see some news out on this stock this Tuesday!!
im sure people are selling because nothing seems to be happening here..
the bid was starting to get more attention today...
FACTS about PDPR,
They've posted 23 videos (well done videos at that)
They've posted at least 50+ GO LIVE photo post (well done videos at that)
They've posted about 100 Social Media post on FB, Twitter and Instagram.
They've posted ZERO news stories via the public market place regarding the Company and or its stock.
And what has that gotten us the shareholders???
NOTHING.. the stock has done NOTHING...
PLEASE explain to me what the strategy is here for us shareholders?
its been a LONG time since the website and app have been done and still NOTHING from the company...things that make you hmmm... not even shareholder update letter..
PLEASE post the so called news that the company has released to the shareholders that is NOT on their social media?
PLEASE stop making all the promo videos that NO ONE cares about, PLEASE invest in a PR firm to start getting noticed in the market place..
i just received NEW email from CRYO, it has a total overview of EVERYTHING this COmpany is doing regarding stem-cells. CRYO (IMO) is going to explode with all the technology it has in the Stem-cell market place.
Check out the overview at the website http://cellstorage.americancryostem.com
they could always release a shareholder update for the market.
have you contacted the company at all in the past week?
looks like the bid and ask are starting to tighten up...
cant get much lower than where its at..lol
CRYO has a NEW website... Looks good !!
where did everyone go.. this board was jumping with comments and just died...lol
i assume we (as shareholders) will not hear anything from this company for a long time.. I hope i'm wrong..
thats a understatement!
agreed with you!! I think they ONLY know how to make cool videos for social media and NOTHING for the shareholders.
yeah right!! lol... what would make you think that?
whatever you say...lol